Pregled bibliografske jedinice broj: 538935
Is Dipeptidyl Peptidase IV (DPP IV) Associated with Inflammation Present in Human Spondyloarthritides and Rheumatoid Arthritis?
Is Dipeptidyl Peptidase IV (DPP IV) Associated with Inflammation Present in Human Spondyloarthritides and Rheumatoid Arthritis? // Croatica chemica acta, 85 (2012), 2; 231-238 doi:10.5562/cca1863 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 538935 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Is Dipeptidyl Peptidase IV (DPP IV) Associated with Inflammation Present in Human Spondyloarthritides and Rheumatoid Arthritis?
Autori
Detel, Dijana ; Kehler, Tatjana ; Buljević, Sunčica ; Pavačić, Irena ; Batičić Pučar, Lara ; Varljen, Neven ; Varljen, Jadranka
Izvornik
Croatica chemica acta (0011-1643) 85
(2012), 2;
231-238
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
Dipeptidyl peptidase IV; Spondyloarthritides; Rheumatoid Arthritis
Sažetak
The dipeptidyl peptidase IV (DPP IV) is a serine peptidase which has been suggested to play a role in the pathogenesis of rheumatoid arthritis, but its mediator actions have not been well investigated in patients with spondyloarthritides. The purpose of this study was to investigate clinical relevance of changes in serum DPP IV activity and concentration in these diseases. Serum DPP IV activity was significantly decreased in patients with spondyloarthritides and rheumatoid arthritis compared to the control group while DPP IV concentration was increased. Among spondyloarthritides patients, DPP IV concentration was decreased in patients with reactive arthritis. No difference was observed in DPP IV activity or concentration between spondyloarthritides and rheumatoid arthritis, as well as between patients with clinically active disease and those in remission. Our results suggest that DPP IV could not be used as a specific serum marker but could be potentially used as a non-specific inflammatory marker.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti
POVEZANOST RADA
Projekti:
062-0061245-0213 - Uloga dipeptidil-peptidaze IV (CD26/DPP IV) u kroničnim bolestima (Varljen, Jadranka, MZOS ) ( CroRIS)
Ustanove:
Medicinski fakultet, Rijeka
Profili:
Sunčica Buljević
(autor)
Tatjana Kehler
(autor)
Lara Batičić
(autor)
Jadranka Varljen
(autor)
Neven Varljen
(autor)
Dijana Detel
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus